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Mammalian Timeless is a multifunctional protein that per-
forms essential roles in the circadian clock, chromosome cohe-
sion, DNA replication fork protection, and DNA replication/
DNA damage checkpoint pathways. The human Timeless exists
in a tight complexwith a smaller protein calledTipin (Timeless-
interacting protein). Here we investigated the mechanism by
which the Timeless-Tipin complex functions as a mediator in
the ATR-Chk1 DNA damage checkpoint pathway. We find that
the Timeless-Tipin complex specifically mediates Chk1 phos-
phorylation byATR in response toDNAdamage and replication
stress through interaction of Tipin with the 34-kDa subunit of
replication protein A (RPA). The Tipin-RPA interaction stabi-
lizes Timeless-Tipin and Tipin-Claspin complexes on RPA-
coated ssDNA and in doing so promotes Claspin-mediated
phosphorylation of Chk1 byATR.Our results therefore indicate
that RPA-covered ssDNA not only supports recruitment and
activation of ATR but also, through Tipin and Claspin, it plays
an important role in the action of ATR on its critical down-
stream target Chk1.
DNA damage and replication checkpoints are controlled by
cellular signal transduction pathways that recognize and
respond to alterations in DNA structure by halting or delaying
cell cycle progression to allow sufficient time for DNA repair
and the completion of DNA replication (1). The phosphoinosi-
tide 3-kinase related kinases ATM2 and ATR play essential
roles in this response by phosphorylating and activating a num-
ber of proteins that function to inhibit cell cycle progression
and promote DNA repair, including p53, Chk1, and Chk2 (1).
Importantly, the disruption of genes involved in the DNAdam-
age checkpoint response is associated with a number of human
diseases, including cancer (1, 2).
Although both ATM and ATR may become activated in
response to different forms of DNA damage, the mechanism
and kinetics of activation are thought to be related to the
types of DNA lesions that are induced by DNA-damaging
agents. Whereas ATM is primarily activated in response to
overt double-strand breaks in DNA induced by ionizing radi-
ation (IR) and related chemical agents (3), ATR is stimulated
under a wider array of genome destabilizing conditions, such
as during replication fork stalling, nucleotide excision repair,
and double-strand break processing and at deprotected
telomeres (1, 4, 5).
Because of the variety of genotoxic stressors that activate
ATR, it has been suggested that a common DNA structural
intermediate may be involved in the initiation or maintenance
of the ATR signal transduction pathway (5–7). Consistent with
this hypothesis, the uncoupling of DNA helicase and polymer-
ase activities at replication forks, resection of DNA ends at dou-
ble-strand breaks, and removal of bulkyDNAadducts by nucle-
otide excision repair all generate single-stranded DNA
(ssDNA) that may become bound by RPA, the major ssDNA-
binding protein in eukaryotes (8, 9). Through a specific inter-
action of the 70-kDa subunit of RPA (RPA1) with the ATR-
interacting protein ATRIP (7, 10, 11), a constitutive binding
partner of ATR (12), RPA is thought to promote the stable
association of ATR-ATRIP with sites of DNA damage and rep-
lication stress. However, full stimulation of ATR kinase activity
requires several additional factors, including the Rad17-repli-
cation factor C complex, which loads the PCNA-like 9-1-1
clamp (Rad9-Hus1-Rad1) onto primer-template junctions that
are also present at sites of DNA damage and at stalled replica-
tion forks (1). Through an interaction with the C-terminal tail
of Rad9, the ATR-activating protein TopBP1 (13) may then be
brought into proximity of ATR where it can stimulate ATR
kinase activity (14).
Although a large number of proteins are potentially phos-
phorylated by ATR in response to DNA damage (15, 16), a pri-
mary checkpoint substrate is the kinase Chk1 (5, 17, 18). Phos-
phorylation of two residues (Ser317 and Ser345) in a C-terminal
regulatory region of Chk1 activates its kinase activity (17, 18)
and changes its subnuclear localization (19), enabling the
phosphorylation of proteins important for DNA repair and
cell cycle progression, such as the Cdc25 family of phospha-
tases, which directly regulate cyclin-dependent kinase activ-
* This work was supported, in whole or in part, by National Institutes of Health
Grants GM32833 (to A. S.), ES014635 (to W. K. K.), ES015856 (to M. C.-S.),
T32-ES07017 (to S. L. S.-R.), and T32-CA09156 (to M. G. K.).
1 To whom correspondence should be addressed: Center for Integrative Biol-
ogy and Biotherapeutics, Pfizer Biopharmaceuticals, 401 N. Middletown
Rd., Pearl River, NY 10965. Tel.: 845-602-2216; Fax: 845-602-5557; E-mail:
unsalkk@wyeth.com.
2 The abbreviations used are: ATM, ataxia telangiectasia mutated; ATR, ATM
and Rad3-related; ATRIP, ATR-interacting protein; IR, ionizing radiation;
RPA, replication protein A; aRPA, alternative RPA; ssDNA, single-stranded
DNA; HU, hydroxyurea; NCS, neocarzinostatin; siRNA, small interfering
RNA; WT, wild type; MCM, minichromosome maintenance.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 285, NO. 22, pp. 16562–16571, May 28, 2010
© 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
16562 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285 • NUMBER 22 • MAY 28, 2010
ity to impact cell cycle progression (20). Chk1 therefore plays
a critical role in the DNA damage checkpoint response and
in promoting genome stability. Its relevance to human
health and disease is further highlighted by the recent devel-
opment of Chk1 inhibitors for clinical use in cancer thera-
pies in combination with traditional chemotherapeutics that
induce DNA damage (21).
The mechanism of how ATR contacts and phosphorylates
Chk1 during the DNA damage response is unclear, although
data from a variety of model systems have demonstrated a
requirement for the Claspin protein as a mediator of this
signaling event (22–26). Initially discovered as a Chk1-inter-
acting protein in Xenopus egg extracts (26), Claspin has been
shown in human cells, Xenopus egg extracts, and reconsti-
tuted ATR kinase reactions to specifically stimulate the
phosphorylation of Chk1 but not the phosphorylation of
other ATR substrate proteins (23, 24, 27). Importantly, like
ATR, Claspin is required for Chk1 phosphorylation and
DNA damage checkpoint signaling in response to agents that
induce a variety of forms of DNA damage (24, 28, 29), indi-
cating that a common mechanism exists for its recruitment
and function in ATR-Chk1 signaling at sites of DNA damage
and replication stress.
We initially reported that the proteinTimeless alsomediated
Chk1 phosphorylation andDNAdamage checkpoint responses
in human cells exposed toUV irradiation or hydroxyurea (HU),
a compound that depletes deoxynucleotide precursors and
causes DNA polymerases to stall (30). In a series of recent
reports, we and others confirmed that both Timeless and its
binding partner Tipin (Timeless-interacting protein) (31) con-
tribute to intra-S and G2/M checkpoint responses to UV, HU,
and other agents, including IR (32–36). Although these differ-
ent agents induce a variety of structural changes to DNA,
including stalled replication forks, nucleotide excision repair
gaps, and double-strand breaks, the observation that the Time-
less-Tipin complex contributes to proper checkpoint responses
to all of these types of damage indicates that a common mech-
anism may be involved in Timeless-Tipin function and/or
recruitment to sites of DNA damage.
Our previous observation that the Timeless-Tipin complex
binds to RPA (32) indicated a possible mechanism for Time-
less-Tipin recruitment and function to promoteATR signaling.
Here we show that the Timeless-Tipin complex specifically
mediates Chk1 phosphorylation by ATR in response to DNA
damage and replication stress through an interaction of Tipin
with the 34-kDa subunit of RPA (RPA2), which stabilizes both
the Timeless-Tipin complex and Claspin on RPA-coated
ssDNA. These results therefore indicate that RPA function in
ATR checkpoint signaling extends beyond recruitment and
activation of ATR and also includes, through Timeless-Tipin
and Claspin, a possible mechanism for facilitating Chk1 phos-
phorylation by ATR at sites of DNA damage.
EXPERIMENTAL PROCEDURES
Cell Lines—HeLa, HEK293T, and FlpTM-In T-RExTM-293
cells (Invitrogen) were maintained in Dulbecco’s minimal
essential medium supplemented with 10% fetal bovine serum
and penicillin-streptomycin. Sf21 and Hi5 cells (Invitrogen)
were grown in Grace’s insect medium (Invitrogen) supple-
mented with 10% fetal bovine serum. Derivation of stable Flp-
InTM T-RExTM-293 cell lines expressing FLAG-tagged Tipin
was performed according to the manufacturer’s protocols
(Invitrogen).
Immunoblotting—Standard immunoblotting procedures
were used to detect proteins in cell lysates and in pull-down
assays with recombinant proteins. Antibodies against Timeless
and Tipin were generously provided by Anthony Gotter and
HisaoMasai (34, 36). Apeptide corresponding to anN-terminal
fragment of Tipin (CSPERQDGEGTEPDEESG) synthesized by
the University of North Carolina Protein Sequence and Peptide
Synthesis Facility was conjugated to keyhole limpet hemocya-
nin by Covance and used to generate an additional rabbit anti-
Tipin antibody used in this work. ATR (N-19), Claspin (H-300),
Chk1 (G-4), Chk2 (H-300), RPA1 (B-6), and XPB (S-19) anti-
bodies were purchased from Santa Cruz. RPA1 and RPA2 anti-
bodies were obtained fromCalbiochem. Phospho-RPA2 (Ser33)
and phospho-MCM2 (Ser108) antibodies were fromBethyl Lab-
oratories. Anti-FLAG and anti-His antibodies were from Sigma
and Abgent, respectively. ORC2 and MEK2 antibodies were
purchased from BD Biosciences. ATRIP antibody was obtained
from Zymed Laboratories Inc.. Phospho-Chk1 (Ser345) anti-
body was from Cell Signaling Technology.
Plasmids—Plasmids used in this work can be obtained from
Addgene. pcDNA3-FLAG-Tipin, pcDNA4-FLAG-Timeless,
and pcDNA3-FLAG-RPA2 were described previously (30, 32,
37). Vectors encoding FLAG-Tipin mutants (E185A, E190A,
and L195A) were generated by site-directed mutagenesis and
were cloned in pcDNA3. To generate siRNA-resistant forms of
Tipin, the region of Tipin targeted by Dharmacon siRNA cata-
log number J-020843 (5-AGAGGACTTCCAGCCTTA-3)
was changed to 5-AGGGGCCTGCCGGCGTTG-3 by site-
directedmutagenesis in the pcDNA3 vector. FLAG-Tipin (WT
and L195A) sequenceswere also subcloned into the BamHI and
XhoI sites of pcDNA5/FRT/TO.
To generate pFastBac1-FLAG-Timeless, pFastBacHTb-
His-FLAG-Timeless (32) was digested with XbaI/KpnI and
the insert ligated into the identical sites in pFastBac1.
pcDNA3-FLAG-Tipin (L195A) was cut with BamHI and XhoI
and inserted into the identical sites of pFastBacHTb to generate
pFastBacHTb-FLAG-Tipin (L195A). To generate pFastBac1-
His-Tipin (L195A), pcDNA3-FLAG-Tipin (L195A) was used as
template in a PCR with previously described primers (32) and
cloned into the XbaI and KpnI sites of pFastBac1.
Tipin (WT and L195A) sequences were also cloned into
the NdeI and XhoI sites of pET21b by PCR using
pcDNA3-FLAG-Tipin (WT or L195A) as a template and the
PCR primers 5-GAAGCTAGAGCACTCGAGCACTGA-3
and 5-TCAGTGCTCGAGTGCTCTAGCTTC-3.
Expression and Purification of Recombinant Proteins—RPA
and aRPA were purified from Escherichia coli as described pre-
viously (38, 39). Baculoviruses used to express and purify pro-
teins from insect cells (Sf21 orHi5 cells; Invitrogen) were either
previously reported (30, 32, 37, 40) or were prepared with the
Bac-to-Bac baculovirus expression system (Invitrogen) using
protocols recommended by the manufacturer. His-FLAG-
Tipin and the FLAG-Timeless/His-Tipin heterodimer were
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purified from baculovirus-infected Sf21 cells as previously
described (32). His-tagged forms of Tipin (WT and L195A)
were also purified from E. coli (BL21-Codon Plus (DE3)-RIPL)
using nickel-nitrilotriacetic acid-agarose (Qiagen).
Transfection—DNA and siRNA transfections in HeLa cells
and Flp-InTM T-RExTM-293 cells employed Lipofectamine
2000 or Lipofectamine RNAiMAX (Invitrogen) using protocols
provided by themanufacturer. HEK293T cells were transfected
with calcium phosphate. The Timeless and Tipin siRNAs were
previously described (30, 32), and the current work utilized an
additional siRNA targeting Tipin (Dharmacon catalog number
J-020843) and the nontargeting control siRNA 2 (Dharmacon
catalog number D-001210-02).
Immobilized DNA Pulldown Assays—An 80-mer biotiny-
lated ssDNA (37) was immobilized on streptavidin-coupled
Dynabeads (M-280) as recommended by the manufacturer
(Dynal), typically at 1 pmol of DNA/l of magnetic beads.
Standard reactions involved incubation of the indicated pro-
teins in 50 l of binding buffer (10 mM Tris, pH 7.4, 100 mM
NaCl, 10% glycerol, 10 g/ml bovine serum albumin, 0.01%
Nonidet P-40) for 30 min at room temperature before col-
lecting the beads on a magnet and washing three times with
200 l of binding buffer. Preincubation of the ssDNA with
RPA was for 20–30 min before washing and addition of the
other indicated proteins. The bound proteins were eluted
and boiled in 1 SDS-PAGE sample buffer (50 mM Tris, pH
6.8, 100 mM dithiothreitol, 1% SDS, 5% glycerol, 0.005%
bromphenol blue), separated by SDS-PAGE, and analyzed by
immunoblotting.
Immunoprecipitation—Immunoprecipitations were per-
formed with anti-FLAG-agarose (Sigma). For immunoprecipi-
tation reactions employing purified proteins, the indicated
proteins were incubated in binding buffer containing anti-
FLAG-agarose for at least 5 h and then washed three times
with 500 l of binding buffer. Bound proteins were eluted in
either binding buffer containing 200 g/ml FLAG peptide
(Sigma) or 2 SDS-PAGE sample buffer. Immunoprecipita-
tions from cell extracts involved incubation of cell lysates
with anti-FLAG-agarose overnight, washes with Tris-buff-
ered saline, and elution with FLAG peptide or 2 SDS-
PAGE sample buffer.
Subcellular Fractionation—Subcellular fractionation of
mammalian cells to enrich for chromatin-bound proteins was
performed essentially as described (41), with the addition of 10
mM NaF, 1 mM Na3VO4, and a 1:200 dilution (v/v) of protease
inhibitor mixture (Sigma) to all buffers. Cytosolic and nuclear
extracts were also prepared fromhuman cell lines, essentially as
described (42).
RESULTS
Timeless-Tipin Mediates Phosphorylation of Chk1 but Not
Other ATR Substrates—Although we and others previously
reported a requirement for the Timeless-Tipin complex for
phosphorylation of the checkpoint kinase Chk1 by ATR in
response to UV irradiation and other agents that induce repli-
cation fork stalling (30, 32–36, 43), it was not determined
whether Timeless-Tipin was required for phosphorylation of
other ATR substrates. We therefore used RNA interference to
reduce Timeless-Tipin protein levels in HeLa cells and then
examined the phosphorylation status of the ATR targets Chk1,
Claspin, RPA2, and MCM2, because these proteins undergo
rapid, ATR-dependent phosphorylation after HU treatment
and are bona fide components of the intra-S phase checkpoint
(17, 18, 28, 29, 44–46). As reported previously (30, 32, 34, 36),
Chk1 displayed significantly less phosphorylation on Ser345 in
HU-treated cells depleted of Timeless-Tipin than in cells trans-
fected with a nontargeting control siRNA (Fig. 1A). Impor-
tantly, the observation that total Chk1 protein levels remained
unchanged under these conditions showed that this reduced
Chk1 phosphorylation was not due to altered Chk1 stability,
because phosphorylation of Chk1 on this residue can trigger its
proteosomal degradation (47, 48).We also noticed that Claspin
failed to undergo a characteristic ATR-dependent mobility
shift after HU treatment in cells depleted of Timeless-Tipin.
BecauseClaspin fails to stably associatewith replication forks in
the absence ofTimeless-Tipin (33, 34, 43), these results indicate
that abnormal regulation of Claspin in cells depleted of Time-
less-Tipin is correlated with defects in Chk1 phosphorylation
by ATR in response to replication stress.
In contrast, no significant defect was observed on the phos-
phorylation status of Ser33 of RPA2, a site that is rapidly phos-
phorylated by ATR after HU treatment and that is important in
regulating RPA function in the intra-S phase checkpoint
response (44, 45). We also observed that control siRNA-
transfected and Timeless-Tipin siRNA-transfected cells exhib-
FIGURE 1. Timeless and Tipin are required to specifically mediate Chk1
phosphorylation in response to DNA damage and replication stress.
A, 48 h after transfection of HeLa cells with either Control (Con), Timeless
(Tim), or Tipin (Tip) siRNA, the cells were treated with 1 mM HU for 30 min. The
lysates were prepared, separated by SDS-PAGE, and analyzed by immuno-
blotting with antibodies against the indicated proteins. B, cells were trans-
fected and analyzed as in A, but cells were instead treated with 100 ng/ml NCS
for 1 h.
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ited similar HU-induced phosphorylation of MCM2 on Ser108,
a known target of ATR (46, 49) and component of the replica-
tive MCM helicase that functions in DNA replication and the
intra-S phase checkpoint response (46, 50). Consistent with a
recent report indicating a role for Timeless-Tipin in coupling
DNA unwinding to DNA synthesis (51), knockdown of Time-
less and Tipin led to a modest increase in the phosphorylation
of RPA2-Ser33 and MCM2-Ser108 compared with cells trans-
fected with a control siRNA (Fig. 1A). Based on the results with
HU treatment, however, we conclude that Timeless-Tipin
activity in ATR-dependent checkpoint signaling is required for
the Claspin-Chk1 pathway but not for ATR to phosphorylate
other checkpoint substrates during the response to replication
stress. Because a similar phenotype has been reported for
Claspin function in ATR signaling after DNA damage or repli-
cation stress (23, 24, 27) and because Claspin fails to stably
associate with replication forks in the absence of Timeless-
Tipin (33, 34, 43), these results indicate that Timeless, Tipin,
and Claspin function together in a common pathway to medi-
ate Chk1 phosphorylation by ATR.
Although Timeless, Tipin, and Claspin have well recognized
roles in mediating Chk1 phosphorylation in response to agents
that inhibit the progression of DNA polymerases, genetic stud-
ies have indicated that these genes also contribute to proper
G2/Mand intra-S checkpoint responses in human cells exposed
to IR (28, 35), suggesting that these proteins function in medi-
ating ATR-dependent checkpoint responses to DNA double-
strand breaks. Although Claspin has been shown to be required
for Chk1 phosphorylation after exposure to IR (24, 28), it was
not clear whether the requirement for Timeless-Tipin in IR-
induced checkpoint activation was related to a requirement for
Chk1 phosphorylation. We therefore treated Timeless-Tipin-
depleted HeLa cells with neocarzinostatin, an IR-mimetic that
generates double-strand breaks in DNA. As shown in Fig. 1B,
NCS treatment in cells depleted of Timeless-Tipin did not
induce Chk1 phosphorylation to the extent observed in control
cells. Importantly, no defect was observed in Chk2 phosphory-
lation, as visualized by a characteristic mobility shift on SDS-
PAGE, indicating normal activation of ATM-Chk2 signaling in
NCS-treated cells lacking Timeless-Tipin. Based on these
results, we conclude that like ATR and Claspin, the Timeless-
Tipin complex is required for Chk1 phosphorylation in human
cells exposed to a variety of different types of DNA-damaging
agents.
RPA Stabilizes Timeless, Tipin, and Claspin on ssDNA—The
requirement for Timeless, Tipin, andClaspin inATR-Chk1 sig-
naling in response to different forms of DNA damage indicates
that a common DNA intermediate may be involved in regulat-
ing their activities at sites of DNA damage and stalled replica-
tion forks. Similarly, a primary mode for recruitment and acti-
vation of the ATR kinase involves the generation of ssDNA
during DNA damage processing and replication fork stalling.
This ssDNA is expected to rapidly become bound by RPA, the
major eukaryotic ssDNA-binding protein that coordinates a
variety of DNA metabolic processes (8, 9). Through a direct
interaction of the constitutively bound ATR-interacting pro-
tein ATRIP with the largest subunit of RPA, the ATR kinase is
thought to be recruited to sites of DNA damage so that it can
phosphorylate its checkpoint substrates (7, 10, 11). Because we
recently reported that Tipin also directly binds to RPA (32), we
considered that the Tipin-RPA interaction may be important
for the functions ofTimeless, Tipin, andClaspin at sites ofDNA
damage and replication stress.
To characterize the interactions of Timeless, Tipin, and
Claspin with RPA and ssDNA, we purified recombinant forms
of these factors using either bacterial or insect expression sys-
tems (Fig. 2A) and tested their direct interactions with one
another and with ssDNA. To examine protein binding to DNA,
we immobilized a biotinylated 80-mer ssDNA on streptavidin-
coupledmagnetic beads and then incubated the DNAwith var-
ious combinations of the indicated proteins, as has been done
previously to study the interactions of RPA and ATRIP on
ssDNA (7, 37). The purified Timeless-Tipin complex did not
stably associate with the 80-mer ssDNA (Fig. 2B, lane 3), but
preincubation of the immobilized ssDNA with RPA imparted
stable binding of Timeless-Tipin (Fig. 2B, lanes 4 and 5). Con-
sistent with our previous report that Tipin mediated the asso-
ciation of the Timeless-Tipin complex with RPA in solution
(32), Timeless was not required for Tipin association with RPA
on ssDNA, because recombinant Tipin alone was capable of
binding to RPA-covered ssDNA but not to ssDNA lacking RPA
(Fig. 2C, lanes 4–7).
Many proteins that interact with RPA make contact with
more than one subunit of the RPA heterotrimer (8), and a
recent yeast-two hybrid analysis identified an interaction
between Tipin and the 34-kDa RPA2 subunit of RPA (36). We
therefore sought to determine the importance of the RPA2 sub-
unit for interactionwithTipin by using a novel, alternative form
of RPA (aRPA) that contains the similarly sizedRPA4protein in
place of RPA2 (39, 52, 53). Although RPA4-containing aRPA
did not support SV40 DNA replication in vitro (39) or cell cycle
progression in human cells (53), we have recently found in
reconstitution assays with purified factors that aRPA supports
nucleotide excision repair (54) and the recruitment and activa-
tion of ATR-ATRIP by ssDNA,3 suggesting that aRPA may
function in general genome maintenance activities but not
DNA replication. Consistent with a recent report that RPA and
aRPA show similar binding affinities toward ssDNA (39), we
found that similar amounts of the shared RPA1 subunit of RPA
and aRPA were retained on the immobilized ssDNA (Fig. 2C).
However, aRPA failed to promote the association of Tipin with
the immobilized ssDNA (Fig. 2C, lanes 8–11). When we incu-
bated RPA or aRPA with a FLAG-tagged form of Tipin immo-
bilized anti-FLAG-agarose, very little aRPA bound to Tipin
(Fig. 2D). We conclude that within the context of the RPA het-
erotrimeric complex, the RPA2 subunit of RPA plays a primary
role in its stable association with Tipin.
Because the Timeless-Tipin complex has been shown to co-
immunoprecipitate with Claspin in human cell extracts and to
be required for the stable association of Claspinwith chromatin
containing stalled replication forks in both human cells and
Xenopus egg extracts (33, 34, 43), we next sought to investigate
the interactions of Claspin with Tipin, RPA, and ssDNA. Using
3 J.-H. Choi and A. Sancar, unpublished data.
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the purified proteins described above, we observed that Tipin
directly bound to a FLAG-tagged form of Claspin immobilized
on anti-FLAG-agarose (Fig. 2E), indicating that Timeless is not
necessary for Tipin to bind to Claspin. We then examined the
association ofClaspinwith the immobilized 80-mer ssDNAand
found that Claspin can bind weakly to ssDNA (Fig. 2F), consis-
tent with previous work (40). However, when the ssDNA was
coated with RPA, Claspin failed to associate with the DNA.
Also, we have never observed any direct interaction of Claspin
with RPA in the absence of DNA (data not shown). Interest-
ingly, when the RPA-coated ssDNA was first incubated with
recombinant Tipin prior to addition of Claspin to the binding
reaction, Claspin was now able to associate with the immobi-
lized DNA (Fig. 2F, lane 3). These results show that Tipin is
necessary and sufficient for Claspin association with RPA-
coated ssDNA, a common intermediate in DNA damage pro-
cessing and replication fork stalling. These data may therefore
explain the requirement for Tipin in the association of Claspin
with chromatin containing stalled replication forks in human
cells and in Xenopus egg extracts (33, 34, 43).
Identification of aMutant Form of Tipin That Does Not Bind
RPA—It was previously noted that Tipin contains a region of
amino acids that show significant similarity to a motif present
in the nucleotide excision repair
protein XPA and other repair pro-
teins that is involved in contacting
the RPA2 subunit of RPA (Fig. 3A)
(31, 32, 55). To further investigate
the importance of the RPA-Tipin
interaction in DNA damage check-
point signaling, we mutated three
amino acids in Tipin that are identi-
cal in human XPA and then exam-
ined the ability of FLAG-tagged
forms of the Tipin mutants to co-
immunoprecipitate with RPA after
expression in HEK293T cells.
Whereas two mutations (E185A
and E190A) did not interfere with
co-precipitation of RPA, mutation
of Leu195 to Ala (L195A) completely
abrogated the RPA interaction (Fig.
3B). Using baculovirus-expressed
FLAG-tagged Tipin-WT andTipin-
L195A immobilized on anti-FLAG
resin, we observed that RPA was
able to bind well to the wild type but
not to the L195A mutant form of
Tipin (Fig. 3C). Similarly, recombi-
nant Tipin-L195A purified from
either E. coli or baculovirus-in-
fected insect cells failed to associate
with immobilized ssDNA covered
with RPA (data not shown). Impor-
tantly, although the L195A muta-
tion altered Tipin mobility on SDS-
PAGE, it did not affect the ability of
Tipin to form complexes with
Timeless when co-expressed in insect cells, but as expected,
Timeless-Tipin complexes containing Tipin-L195A were
unable to associate with RPA-coated ssDNA in vitro (Fig. 3D).
Similarly, Tipin-WT and Tipin-L195A bound equivalently to
FLAG-Claspin immobilized on anti-FLAG-agarose (Fig. 3E),
but the Tipin-L195A mutant did not promote Claspin associa-
tion with immobilized ssDNA coated with RPA (Fig. 3F). We
conclude that the L195A mutation in Tipin specifically affects
its ability to interact with RPA but not to either Timeless or
Claspin.
Expression and Nuclear Localization of Timeless-Tipin—We
next wished to test whether the RPA-Tipin interaction was
required for Chk1 phosphorylation by ATR in genotoxin-
treated human cells. Our initial experiments using transient
transfection of plasmid vectors expressing siRNA-resistant
forms of Tipin and siRNAs targeting endogenous Tipin were
inconclusive. Because siRNA-mediated knockdown of either
Timeless or Tipin affects the stability and nuclear localization
of the corresponding binding partner (32, 34–36), we first
examined the ability of FLAG-tagged forms of Timeless and
Tipin to form complexes with the endogenous binding partner
in human cells. Whereas FLAG-Timeless readily co-immuno-
precipitated 20–25% of endogenous Tipin in transiently
FIGURE 2. Interaction between RPA2 and Tipin stabilizes Timeless-Tipin and Claspin on RPA-coated
ssDNA. A, Coomassie Blue-stained gel of purified proteins. RPA, aRPA, and Tipin-His were purified from E. coli,
and His-FLAG-Tipin (HF-Tipin), His-FLAG-Timeless/His-Tipin (HF-Tim/His-Tip), and His-FLAG-Claspin (HF-
Claspin) were purified from baculovirus-infected insect cells. Note that the gel displays only the 70-kDa (RPA1)
and 34-kDa (RPA2/RPA4) subunits of RPA and aRPA, because the 17-kDa (RPA3) subunit was electrophoresed
off of the gel. Lane 1 contains a molecular weight ladder, where numbers indicate molecular mass in kDa.
B, His-FLAG-Timeless/His-Tipin complex (Tim/Tip; 10 pmol) was incubated with 5 pmol of immobilized 80-mer
ssDNA preincubated for 30 min with 0, 2.5, or 5 pmol RPA in binding buffer. Input represents 5 pmol of
HF-Timeless/His-Tipin complex and 5 pmol RPA. C, ssDNA (1 pmol) was preincubated with 0, 0.2, 0.5, or 1.25
pmol of RPA or aRPA in 50 l of binding buffer before washing and addition of 20 pmol of Tipin. Input shows 0.5
pmol of RPA or aRPA and 1 pmol of Tipin. D, His-FLAG-tagged Tipin from baculovirus-infected insect cells was
immobilized on anti-FLAG-agarose and then incubated with 1 g of either RPA or aRPA overnight at 4 °C in 100
l of binding buffer. Input represents 5% of the binding reactions. E, Tipin-His purified from E. coli (1 g) was
incubated with anti-FLAG resin alone or resin containing His-FLAG-tagged Claspin from baculovirus-infected
insect cells. The reactions were in 100 l of binding buffer overnight at 4 °C. Input shows 5% of the indicated
reactions. Heavy chain of anti-FLAG IgG is displayed as a loading control. F, immobilized ssDNA (5 pmol) was
incubated with RPA (10 pmol), His-FLAG-Tipin (10 pmol), and/or His-FLAG-Claspin (10 pmol), as indicated, and
bound proteins were analyzed as in B and C. IP, immunoprecipitation.
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transfected HEK293T cells and led to a slight (2–3-fold)
increase in total Tipin protein levels in the cells (Fig. 4A, left
panel), very little endogenous Timeless (1%) co-immunopre-
cipitated with the ectopically expressed FLAG-Tipin (Fig. 4A,
right panel). These results suggested to us that Tipin protein
stability or heterodimeric complex formation with Timeless
may be dependent upon the presence of sufficient levels of free
Timeless protein in the cell, although we cannot rule out the
possibility that some other property of the ectopically
expressed Tipin interferes with its ability to form complexes
with Timeless.
We next tested whether the ectopically expressed Tipin
properly localized to the nuclear fraction of cells, because it has
been reported that co-transfection of vectors encoding both
Timeless and Tipin in NIH3T3 cells greatly enhanced the
nuclear retention of the ectopically expressed Tipin (31). Fur-
thermore, previous immunofluorescence microscopy studies
showed that the majority of endogenous Timeless and Tipin
protein are found in nuclei (34–36), but knockdown of either
protein results in the residually expressed binding partner
localizing to the cytosol instead (34). We therefore sought to
confirm these results and monitor the localization of ectopi-
cally expressed Timeless and Tipin by using subcellular frac-
tionation procedures. Lysis of HEK293T cells in hypotonic
buffers resulted in60%of the endogenousTimeless andTipin
to be released from nuclei and be detected in the cytosolic frac-
tion (Fig. 4B), similar to the distri-
bution of RPA, of which a large frac-
tion is known to be readily extracted
from nuclei under hypotonic condi-
tions (56). We then expressed
FLAG-Timeless and FLAG-Tipin
alone or in combination in
HEK293T cells and then examined
the protein expression level and
localization by subcellular fraction-
ation.Maximal FLAG-Timeless and
FLAG-Tipin protein levels and
enrichment in a high salt nuclear
extract required co-transfection of
vectors encoding both proteins (Fig.
4C). Using a different protocol to
generate detergent-soluble and -re-
sistant fractions (41), we further
found enrichment of both FLAG-
Tipin-WT and FLAG-Tipin-L195A
in a detergent-resistant, chromatin-
enriched fraction in HEK293T cells
when FLAG-Timeless was co-ex-
pressed (Fig. 4D). Collectively, these
results suggested that functional
analysis of ectopically expressed
Tipin may require Timeless co-ex-
pression to enable stable formation
and nuclear localization of Timeless-
Tipin complexes.
We also generated stableHEK293
lines that express FLAG-tagged
forms of Tipin-WT and Tipin-L195A under control of a tetra-
cyline-inducible promoter to study the interaction of Tipin
with Timeless and other checkpoint factors. As shown in Fig.
4E, this approach yielded FLAG-Tipin that co-precipitated
with a much larger fraction of endogenous Timeless than with
transient transfection (Fig. 4A, compare input and immunopre-
cipitation signals). Interestingly, constitutive expression of
FLAG-Tipin-WT and FLAG-Tipin-L195A led to expression of
both forms of FLAG-Tipin at levels 2–3-fold higher than
endogenous, untagged Tipin (data not shown) but had no
observable effect on cell growth rate (data not shown), suggest-
ing that neither the FLAG tag nor the L195A mutation affects
Tipin activity in cell proliferation under nonstressed condi-
tions. Because we previously reported that Timeless co-im-
munoprecipitated with ATR and ATRIP in human cells (30),
we tested whether FLAG-Tipin-WT and FLAG-Tipin-
L195A were capable of forming complexes with ATR-ATRIP
in these cells. Interestingly, ATR and ATRIP both co-immu-
noprecipitated with FLAG-Tipin-WT but co-immunopre-
cipitated only weakly with FLAG-Tipin-L195A (Fig. 4F),
suggesting that the interaction of Timeless-Tipin with ATR-
ATRIP is mediated in large part through RPA. Importantly,
equivalent amounts of Claspin were co-immunoprecipitated
with both forms of Tipin, consistent with results using puri-
fied recombinant proteins (Fig. 3E) and indicating that
FIGURE 3. Identification and characterization of a Tipin RPA-binding mutant. A, alignment of XPA and
Tipin amino acid sequences. Black shading shows amino acid identity, and gray shading highlight indicates
similarity. B, FLAG-tagged forms of Tipin were transiently expressed in HEK293T cells, immunoprecipitated
with anti-FLAG-agarose, and analyzed by SDS-PAGE and immunoblotting with antibodies against FLAG, RPA1,
and RPA2. Note that mutation of these amino acids alters Tipin mobility on SDS-PAGE. C, His-FLAG-tagged
Tipin (HF-Tipin; WT and L195A) from baculovirus-infected insect cells was immobilized on anti-FLAG-agarose
and then incubated with RPA. Resin was washed, and bound proteins were analyzed by SDS-PAGE and immu-
noblotting. D, FLAG-Timeless/His-Tipin (Tim/Tip) complexes prepared by baculoviral co-infection and anti-
FLAG-agarose purification were incubated with immobilized ssDNA containing saturating amounts of RPA.
Bound proteins were analyzed by SDS-PAGE and immunoblotting. Input represents 50% of the Timeless-Tipin
complex used in the binding reaction. E, His-FLAG-tagged Claspin (HF-Claspin) from baculovirus-infected
insect cells and immobilized on anti-FLAG resin (lanes 1–3) was incubated overnight at 4 °C with 1.5 g of either
Tipin-His-WT or Tipin-His-L195A purified from E. coli in 100 l of binding buffer. Anti-FLAG resin lacking Claspin
was used as a negative control (lanes 4 –5). Input represents 5% of the Tipin used in the binding reaction.
F, immobilized 80-mer ssDNA lacking or containing saturating amounts of RPA was incubated in reactions with
HF-Claspin alone or together with HF-Tipin-WT or HF-Tipin-L195A. The beads were washed, and bound pro-
teins were analyzed by SDS-PAGE and immunoblotting. IP, immunoprecipitation.
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Tipin-L195A may potentially sequester Claspin from func-
tioning in ATR-Chk1 signaling.
Tipin-L195A Abrogates Chk1 Phosphorylation after Geno-
toxic Stress—With Timeless-Tipin complex expression and
nuclear localization conditions optimized, we transiently trans-
fected HeLa cells with vectors encoding FLAG-Timeless and
either FLAG-Tipin-WT or FLAG-Tipin-L195A that were
made resistant to siRNA by modification of the Tipin cDNA
sequence. Approximately 27 h after co-transfection of these
vectors with either nontargeting control siRNA or siRNA tar-
geting endogenous Tipin, the cells were treated with HU for 30
min to induce activation of ATR. Under these conditions we
observed a nearly complete abrogation of HU-induced Chk1
phosphorylation in cells expressing FLAG-Tipin-L195A and
transfected with siRNA targeting
endogenous Tipin, in comparison
with cells expressing FLAG-
Tipin-WT (Fig. 5A, compare lanes
4 and 8). Although the effect was
much more pronounced when
endogenous Tipin levels were
reduced by siRNA transfection, an
approximately 40% reduction in
Chk1 phosphorylation was ob-
served in control siRNA-trans-
fected cells expressing FLAG-
Tipin-L195A (Fig. 5, A, lanes 3 and
7, and B), suggesting that this form
of Tipin acts in a dominant nega-
tive manner to interfere with Chk1
phosphorylation during replica-
tion stress.
Because Tipin contributes to
DNA damage checkpoint activation
and Chk1 phosphorylation in re-
sponse to agents that induce dou-
ble-strand breaks in DNA (35) (Fig.
1B), we examined the Chk1 phos-
phorylation status in NCS-treated
HeLa cells expressing Tipin-WT or
Tipin-L195A and transfected with
siRNA targeting endogenous Tipin.
As shown in Fig. 5C, we observed a
3–4-fold reduction in Chk1 phos-
phorylation after NCS treatment
in FLAG-Tipin-L195A-expressing
cells comparedwith cells expressing
FLAG-Tipin-WT. These results
indicate that the RPA-Tipin inter-
action is important for Chk1 phos-
phorylation in response to multiple
genotoxic stressors.
Similar results were obtained
with a HEK293 cell line capable of
expressing a siRNA-resistant form
of FLAG-Tipin-L195A upon induc-
tion with tetracycline. As shown in
Fig. 5D, expression of FLAG-Tipin-
L195A under conditions where endogenous Tipin was reduced
via RNA interference caused a significant abrogation of HU-
induced Chk1 phosphorylation. Importantly, no significant
effect was observed on the phosphorylation of RPA2 at Ser33
under these conditions, demonstrating that Tipin-L195A
expression does not interfere with the ability of ATR to phos-
phorylate other substrates.
Because we showed that Tipin was required for Claspin to
stably associate with RPA-coated ssDNA in vitro, we fraction-
ated untreated or HU-treated HEK293T cells expressing
FLAG-Timeless along with either FLAG-Tipin-WT or FLAG-
Tipin-L195A to enrich for chromatin-associated proteins. As in
HeLa cells, we observed a dominant negative effect of theTipin-
L195A mutant on phosphorylation of Chk1 after HU (Fig. 5E).
FIGURE 4. Characterization of Tipin protein expression and nuclear localization in human cells. A, an
empty vector (Vec) and vectors encoding FLAG-Timeless (F-Tim; left panel) or FLAG-Tipin (F-Tip; right panel)
were transiently transfected into HEK293T cells. The lysates were prepared and then immunoprecipitated (IP)
with anti-FLAG resin. Input lanes show 5% of the lysate used for immunoprecipitation. B, HEK293T cells frac-
tionated to yield a hypotonic cytosolic (Cyto) extract and a high salt nuclear (Nuc) fraction were separated by
SDS-PAGE and immunoblotted with antibodies against the indicated proteins. C, HEK293T cells were trans-
fected with an empty vector (lanes 1 and 7), vectors expressing FLAG-Tipin and increasing amounts of FLAG-
Timeless (lanes 2–5 and 8 –11), or a vector expressing FLAG-Timeless alone (lane 6 and 12). The total amount of
plasmid DNA used per transfection (15 g) was identical and was normalized with an empty vector plasmid
DNA. The cells were fractionated as in B to yield cytosolic and nuclear fractions. D, HEK293T cells were trans-
fected with empty vector or vectors expressing FLAG-Tipin and/or FLAG-Timeless, as indicated. The cells were
fractionated to yield Triton-soluble (soluble cytosolic), soluble nuclear, or chromatin-enriched extracts. E, Flp-
InTM T-RExTM-293 cell lines were generated to express FLAG-Tipin-WT or FLAG-Tipin-L195A under control of a
tetracycline-inducible promoter. Uninduced ( Tetracycline) or cells induced with tetracycline ( Tetracycline)
for 3 days were lysed and immunoprecipitated with anti-FLAG-agarose, and the immunoprecipitates were
probed for Timeless and Tipin. Input represents 5% of the lysate used for the immunoprecipitation. F, nuclear
extracts from HEK293T or induced Flp-InTM T-RExTM-293-FLAG-Tipin (WT and L195A) were immunoprecipi-
tated with anti-FLAG resin, separated by SDS-PAGE, and immunoblotted with antibodies against the indicated
proteins.
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Importantly, in comparison with cells expressing wild type
Tipin, we observed a reduction in the level of chromatin-asso-
ciated Claspin after HU treatment in cells expressing Tipin-
L195A, suggesting that the interaction of Tipin with RPA may
be required to stabilize the association of Claspin with chroma-
tin at sites of replication stress. We repeatedly observed no
difference in chromatin association between Tipin-WT and
Tipin-L195A, either in the absence or presence of HU (Fig.
5E), indicating that the Tipin-RPA interaction is not essen-
tial to recruit or stabilize the Timeless-Tipin complex on
bulk chromatin. This observation is consistent with a recent
report showing that Timeless and
Tipin associate with undamaged
chromatin in Xenopus egg extracts
depleted of RPA (33). Whether
Tipin stably associates with RPA
at sites of DNA damage and repli-
cation stress is unclear, because
we have not observed co-localiza-
tion of Tipin with RPA by indirect
immunofluorescence microscopy
(data not shown). However, nei-
ther Claspin nor Chk1 stably asso-
ciates with RPA-ssDNA compart-
ments by immunofluorescence
microscopy either (24, 57), indi-
cating that like Claspin and Chk1,
Tipin function at sites of DNA
damage may be transient or
dynamic to facilitate turnover or
release of phosphorylated, active
Chk1 kinase.
Although we observed a reduc-
tion in Claspin association with
chromatin in HU-treated HEK293T
cells expressing Tipin-L195A, we
noticed that Claspin protein levels
were also reduced in the soluble
fraction of cells as well. To confirm
this reduction and to compare the
kinetics of Claspin loss with Chk1
phosphorylation status, we per-
formed time course experiments in
HU-treated Flp-In T-REx-293 cells
stably expressing siRNA-resistant
FLAG-Tipin-L195A and trans-
fected with either control or Tipin
siRNA. As shown in Fig. 5F, we
observed that the loss of Claspin
protein appeared slightly delayed
relative to the reduction in Chk1
phosphorylation, indicating that
the Claspin loss may be a conse-
quence and not a cause of reduced
ATR-Chk1 signaling. This is con-
sistent with the observation that
genetic or chemical abrogation of
the ATR-Chk1 signaling pathway
leads to the proteosomal degradation of Claspin (58).
DISCUSSION
Currently available data indicate that the ATR kinase is acti-
vated by multiple mechanisms in response to DNA damage,
including its recruitment to the sites of damage by repair pro-
teins and the direct recognition of DNA damage by checkpoint
factors (59–65). However, the predominant signal for the
ATR-Chk1 signaling pathway appears to be RPA-coated
ssDNA that is generated as a common intermediate of replica-
tion stress and damage processing by double-strand break and
FIGURE 5. Tipin-L195A does not support maintenance of Chk1 phosphorylation in response to DNA
damage and replication stress. A, HeLa cells transiently transfected with vectors encoding FLAG-Timeless
and siRNA-resistant FLAG-Tipin (WT or L195A) and either a nontargeting control (Con) siRNA or an siRNA
targeting Tipin (Tip) were treated with 1 mM HU for 30 min. B, quantitation of phospho-Chk1 signals from
experiments performed as in A. Phospho-Chk1 signals for each HU-treated sample were normalized to cells
transfected with control siRNA and FLAG-Tipin-WT. The data show the averages and standard deviation from
three independent experiments. C, HeLa cells transiently transfected with Tipin siRNA and vectors encoding
FLAG-Timeless and siRNA-resistant FLAG-Tipin (WT or L195A) were treated with 100 ng/ml NCS for 1 h. D, unin-
duced ( Tet) and induced ( Tet) Flp-In T-REx-293-FLAG-Tipin-L195A (siRNA-resistant) cells were transfected
with either a control siRNA or an siRNA targeting endogenous Tipin and then treated with 1 mM HU for 2 h.
E, HEK293T cells transfected with vectors expressing FLAG-Timeless and either FLAG-Tipin-WT or FLAG-Tipin-
L195A were treated with 1 mM HU for 6 h or left untreated before fractionation to enrich for chromatin-
associated proteins. Lysate from an equivalent number of cells was separated by SDS-PAGE and immuno-
blotted with antibodies against the indicated proteins. F, Flp-In T-REx-293-FLAG-Tipin-L195A cells
induced with tetracycline to express FLAG-Tipin-L195A (siRNA-resistant) were transfected with either
control or Tipin siRNA and then treated with 1 mM HU for the indicated lengths of time. The graph shows
average Chk1 phosphorylation at each time point, relative to untreated control, from two independent
experiments.
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nucleotide excision repair pathways.ATR stably associateswith
RPA-coated ssDNA through direct interaction of the ATRIP
subunit of the ATR-ATRIP heterodimer with the 70-kDa RPA1
subunit of RPA (6, 7). An issue that has not been widely
addressed is precisely how the key substrate of ATR, the Chk1
signal transducing kinase, interacts with ATR on DNA. Our
data now provide a potential mechanism: through a direct
interaction of the Tipin subunit of the Timeless-Tipin complex
with the 34-kDa RPA2 subunit of RPA. Further, we show that
Timeless-Tipin serves as a platform for ATR-Claspin interac-
tion that is essential for efficient phosphorylation of Chk1 by
ATR (Fig. 6). Importantly, because Claspin and Chk1 do not
appear to stably associate with sites of DNA damage (24, 57),
Tipinmay similarly only transiently interactwithRPAandATR
to facilitate the release of phosphorylated, active Chk1 from
sites of damage so that Chk1 can perform its checkpoint func-
tions throughout the nucleus. Clearly additional work is neces-
sary to better understand the mechanism of ATR-Chk1 signal-
ing, and ultimately this model for Tipin function will need to be
tested experimentally in vitrowith purified factors. It should be
noted that an in vitro system for Claspin-mediated phosphory-
lation of Chk1 by ATR has been reconstituted with purified
human checkpoint proteins (23), and with this system it has
been possible to demonstrate, for the first time, that RPA-
ssDNA can directly stimulate ATR kinase activity.3 The avail-
ability of these defined in vitro systems should eventually enable
us to test and refine the model we have proposed for Timeless-
Tipin in ATR-Chk1 signaling.
It should also be noted that theATR-Chk1 signaling pathway
is a potential target for cancer therapy. Through abrogation of
cell cycle checkpoint function, inhibitors of this pathway are
expected to sensitize cancer cells to chemotherapeutic agents
by forcing cells containing DNA damage and/or unreplicated
DNA to undergo catastrophic mitoses. The development of
small molecules that inhibit Chk1 kinase activity for use in
combination therapies with traditional chemotherapeutics
supports this hypothesis (21). Because the Tipin-RPA interac-
tion site is now known, our studies suggest that a peptide inhib-
itor or chemical compound that prevents the interaction of
Tipin with RPA could potentially serve as a useful therapeutic
agent to sensitize cancer cells to DNA damage-inducing che-
motherapeutic drugs.
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30. Unsal-Kaçmaz, K., Mullen, T. E., Kaufmann, W. K., and Sancar, A. (2005)
Mol. Cell. Biol. 25, 3109–3116
31. Gotter, A. L. (2003) J. Mol. Biol. 331, 167–176
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37. Unsal-Kaçmaz, K., and Sancar, A. (2004)Mol. Cell. Biol. 24, 1292–1300
38. Henricksen, L. A., Umbricht, C. B., and Wold, M. S. (1994) J. Biol. Chem.
269, 11121–11132
39. Mason,A.C.,Haring, S. J., Pryor, J.M., Staloch, C.A.,Gan, T. F., andWold,
M. S. (2009) J. Biol. Chem. 284, 5324–5331
40. Sar, F., Lindsey-Boltz, L. A., Subramanian,D., Croteau,D. L., Hutsell, S.Q.,
Griffith, J. D., and Sancar, A. (2004) J. Biol. Chem. 279, 39289–39295
41. Méndez, J., and Stillman, B. (2000)Mol. Cell. Biol. 20, 8602–8612
42. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983)Nucleic Acids Res.
11, 1475–1489
43. Errico, A., Costanzo, V., and Hunt, T. (2007) Proc. Natl. Acad. Sci. U.S.A.
104, 14929–14934
44. Olson, E., Nievera, C. J., Klimovich, V., Fanning, E., and Wu, X. (2006)
J. Biol. Chem. 281, 39517–39533
45. Vassin, V.M., Anantha, R.W., Sokolova, E., Kanner, S., and Borowiec, J. A.
(2009) J. Cell Sci. 122, 4070–4080
46. Cortez, D., Glick, G., and Elledge, S. J. (2004) Proc. Natl. Acad. Sci. U.S.A.
101, 10078–10083
47. Zhang, Y. W., Otterness, D. M., Chiang, G. G., Xie, W., Liu, Y. C., Mercu-
rio, F., and Abraham, R. T. (2005)Mol. Cell 19, 607–618
48. Zhang, Y.W., Brognard, J., Coughlin, C., You, Z., Dolled-Filhart, M., Asla-
nian, A.,Manning, G., Abraham, R. T., andHunter, T. (2009)Mol. Cell 35,
442–453
49. Yoo, H. Y., Shevchenko, A., Shevchenko, A., and Dunphy, W. G. (2004)
J. Biol. Chem. 279, 53353–53364
50. Tsao, C. C., Geisen, C., and Abraham, R. T. (2004) EMBO J. 23,
4660–4669
51. Smith, K. D., Fu, M. A., and Brown, E. J. (2009) J. Cell Biol. 187, 15–23
52. Keshav, K. F., Chen, C., and Dutta, A. (1995) Mol. Cell. Biol. 15,
3119–3128
53. Haring, S. J., Humphreys, T. D., andWold, M. S. (2010)Nucleic Acids Res.
38, 846–858
54. Kemp, M. G., Mason, A. C., Carreira, A., Reardon, J. T., Haring, S. J.,
Borgstahl, G. E., Kowalczykowski, S. C., Sancar, A., andWold,M. S. (2010)
J. Biol. Chem. 285, 4788–4797
55. Mer, G., Bochkarev, A., Gupta, R., Bochkareva, E., Frappier, L., Ingles, C. J.,
Edwards, A. M., and Chazin, W. J. (2000) Cell 103, 449–456
56. Fairman, M. P., and Stillman, B. (1988) EMBO J. 7, 1211–1218
57. Bekker-Jensen, S., Lukas, C., Kitagawa, R., Melander, F., Kastan, M. B.,
Bartek, J., and Lukas, J. (2006) J. Cell Biol. 173, 195–206
58. Chini, C. C., Wood, J., and Chen, J. (2006) Oncogene 25, 4165–4171
59. Choi, J. H., Lindsey-Boltz, L. A., and Sancar, A. (2007)Proc. Natl. Acad. Sci.
U.S.A. 104, 13301–13306
60. Jiang, G., and Sancar, A. (2006)Mol. Cell. Biol. 26, 39–49
61. Choi, J. H., Lindsey-Boltz, L. A., and Sancar, A. (2009) Nucleic Acids Res.
37, 1501–1509
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